Ignite Creation Date:
2025-12-25 @ 2:15 AM
Ignite Modification Date:
2025-12-26 @ 6:21 PM
Study NCT ID:
NCT00372060
Status:
COMPLETED
Last Update Posted:
2017-05-12
First Post:
2006-09-05
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
MK0431 (Sitagliptin) Pioglitazone Add-on Study for Patients With Type 2 Diabetes Mellitus (0431-055)(COMPLETED)
Sponsor:
Merck Sharp & Dohme LLC
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2006-08-21
Start Date Type:
ACTUAL
Primary Completion Date:
2008-02-05
Primary Completion Date Type:
ACTUAL
Completion Date:
2008-02-05
Completion Date Type:
ACTUAL
First Submit Date:
2006-09-05
First Submit QC Date:
None
Study First Post Date:
2006-09-06
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2009-01-27
Results First Submit QC Date:
None
Results First Post Date:
2009-03-31
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2017-04-06
Last Update Post Date:
2017-05-12
Last Update Post Date Type:
ACTUAL